<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://actutrading.com/en/article/tesla-holds-onto-its-bitcoin-despite-a-dollar112-million-loss-in-q2</loc>
    <lastmod>2026-07-23T22:33:06.424Z</lastmod>
    <image:image>
      <image:loc>https://actutrading.com/uploads/generated/1784785961492-07b33250ded6.webp</image:loc>
      <image:title>Tesla Holds onto Its Bitcoin Despite a $112 Million Loss in Q2</image:title>
      <image:caption>Elon Musk and Tesla held onto their entire Bitcoin holdings in Q2 2026, despite $112 million in unrealized losses. This sends a strong signal to the crypto market.</image:caption>
      <image:license>https://actutrading.com/en/mentions-legales</image:license>
    </image:image>
    <news:news>
      <news:publication>
        <news:name>ActuTrading</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-23T05:52:47.893Z</news:publication_date>
      <news:title>Tesla Holds onto Its Bitcoin Despite a $112 Million Loss in Q2</news:title>
      <news:keywords>Tesla, Bitcoin, BTC, Elon Musk, institutional crypto, crypto, bitcoin, ethereum, blockchain, cryptomonnaies</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://actutrading.com/fr/article/tesla-conserve-ses-bitcoin-malgre-112-millions-de-pertes-sur-le-t2</loc>
    <lastmod>2026-07-23T22:28:55.607Z</lastmod>
    <image:image>
      <image:loc>https://actutrading.com/uploads/generated/1784785961492-07b33250ded6.webp</image:loc>
      <image:title>Tesla conserve ses Bitcoin malgré 112 millions de pertes sur le T2</image:title>
      <image:caption>Elon Musk et Tesla ont conservé la totalité de leur stock de Bitcoin au T2 2026, malgré 112 millions de dollars de pertes latentes. Un signal fort pour le marché crypto.</image:caption>
      <image:license>https://actutrading.com/fr/mentions-legales</image:license>
    </image:image>
    <news:news>
      <news:publication>
        <news:name>ActuTrading</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-07-23T05:52:47.893Z</news:publication_date>
      <news:title>Tesla conserve ses Bitcoin malgré 112 millions de pertes sur le T2</news:title>
      <news:keywords>Tesla, Bitcoin, BTC, Elon Musk, crypto institutionnel, crypto, bitcoin, ethereum, blockchain, cryptomonnaies</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://actutrading.com/fr/article/trump-frappe-la-pharma-indienne-chute-brutale-a-bombay</loc>
    <lastmod>2026-07-23T22:27:32.107Z</lastmod>
    <image:image>
      <image:loc>https://actutrading.com/uploads/generated/1784721161645-bf8731d1126e.webp</image:loc>
      <image:title>Trump frappe la pharma indienne : chute brutale à Bombay</image:title>
      <image:caption>Donald Trump cible les génériques indiens. Les actions pharmaceutiques de Bombay ont chuté brutalement après l&apos;annonce de nouveaux tarifs douaniers américains.</image:caption>
      <image:license>https://actutrading.com/fr/mentions-legales</image:license>
    </image:image>
    <news:news>
      <news:publication>
        <news:name>ActuTrading</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-07-22T11:52:53.199Z</news:publication_date>
      <news:title>Trump frappe la pharma indienne : chute brutale à Bombay</news:title>
      <news:keywords>Trump, pharma, Inde, tarifs douaniers, génériques, Sun Pharma, Sanofi, USD/INR, Bombay, commerce international</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://actutrading.com/en/article/trump-hits-indian-pharma-sector-sharp-drop-in-mumbai</loc>
    <lastmod>2026-07-23T22:31:42.783Z</lastmod>
    <image:image>
      <image:loc>https://actutrading.com/uploads/generated/1784721161645-bf8731d1126e.webp</image:loc>
      <image:title>Trump Hits Indian Pharma Sector: Sharp Drop in Mumbai</image:title>
      <image:caption>Donald Trump is targeting Indian generic drugs. Pharmaceutical stocks in Mumbai plummeted following the announcement of new U.S. tariffs.</image:caption>
      <image:license>https://actutrading.com/en/mentions-legales</image:license>
    </image:image>
    <news:news>
      <news:publication>
        <news:name>ActuTrading</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-22T11:52:53.199Z</news:publication_date>
      <news:title>Trump Hits Indian Pharma Sector: Sharp Drop in Mumbai</news:title>
      <news:keywords>Trump, pharmaceutical industry, India, customs tariffs, generic drugs, Sun Pharma, Sanofi, USD/INR, Mumbai, international trade</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://actutrading.com/en/article/ubs-raises-its-sandampp-500-target-to-8100-points-for-the-end-of-2025</loc>
    <lastmod>2026-07-23T22:30:19.177Z</lastmod>
    <image:image>
      <image:loc>https://actutrading.com/uploads/generated/1784699563454-20eb4a4577b6.webp</image:loc>
      <image:title>UBS raises its S&amp;amp;P 500 target to 8,100 points for the end of 2025</image:title>
      <image:caption>The Swiss bank has raised its S&amp;amp;P 500 target from 6,600 to 8,100 points. The reason: corporate earnings that are significantly underestimated by the consensus.</image:caption>
      <image:license>https://actutrading.com/en/mentions-legales</image:license>
    </image:image>
    <news:news>
      <news:publication>
        <news:name>ActuTrading</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-22T05:52:50.712Z</news:publication_date>
      <news:title>UBS raises its S&amp;amp;P 500 target to 8,100 points for the end of 2025</news:title>
      <news:keywords>S&amp;amp;P 500, UBS, U.S. indices, Wall Street, corporate earnings, actions, bourse, indices, marchés boursiers, stocks</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://actutrading.com/fr/article/ubs-releve-sa-cible-setp-500-a-8-100-points-pour-fin-2025</loc>
    <lastmod>2026-07-23T22:26:09.139Z</lastmod>
    <image:image>
      <image:loc>https://actutrading.com/uploads/generated/1784699563454-20eb4a4577b6.webp</image:loc>
      <image:title>UBS relève sa cible S&amp;P 500 à 8 100 points pour fin 2025</image:title>
      <image:caption>La banque suisse rehausse son objectif S&amp;P 500 de 6 600 à 8 100 points. En cause : des bénéfices d&apos;entreprises largement sous-estimés par le consensus.</image:caption>
      <image:license>https://actutrading.com/fr/mentions-legales</image:license>
    </image:image>
    <news:news>
      <news:publication>
        <news:name>ActuTrading</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-07-22T05:52:50.712Z</news:publication_date>
      <news:title>UBS relève sa cible S&amp;P 500 à 8 100 points pour fin 2025</news:title>
      <news:keywords>S&amp;P 500, UBS, indices US, Wall Street, bénéfices entreprises, actions, bourse, indices, marchés boursiers, stocks</news:keywords>
    </news:news>
  </url>
</urlset>